Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Thirona logo — AI-powered lung image analysis

Thirona

AI-powered lung image analysis

Founded 2014 The Netherlands The Netherlands 83 employees Total: $15.00M Analytics, Health Care

General Information

Company Name Thirona
Founded Year 2014
Location The Netherlands The Netherlands
Employees 83
Industries Analytics, Health Care
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Project Based
Offices as of Aug 2026
Nijmegen, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with Thirona. To contact Thirona, visit thirona.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Thirona compare?

A PDF of Thirona and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Thirona soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Thirona

Thirona, founded in 2014 and headquartered in The Netherlands, is at the forefront of innovation in the Analytics and Health Care industries. The company specializes in AI-powered lung image analysis, offering advanced tools for thoracic imaging through its LungQ® portfolio.

Thirona's technology stands out due to its robust segmentation capabilities, providing precise quantification of bronchial, parenchymal, and vascular lung structures. The efficacy and reliability of these solutions are backed by over 200 peer-reviewed publications, attesting to their reproducibility across varied populations and disease severities.

The company collaborates with acclaimed research institutes, academic hospitals, pharmaceutical innovators, and MedTech partners. Presently, LungQ® is operational in over 1,200 hospitals worldwide. Thirona's commitment to advancing precision medicine is reinforced by a recent €5.00M Series B investment on 01 September 2023, led by Borski Fund and HERAN Partners, enabling further growth and innovation.

Business keywords: AI-powered Analysis, Thoracic Imaging, Lung Segmentation, Pulmonary Diseases, Quantification of Lung Structures, Respiratory Clinical Trials, Precision Medicine, Medical Imaging, Minimally Invasive Interventions, Image Analysis

Services & Products

AI-enabled lung image analysis
Advanced segmentation and quantification
Support for clinical trials in drug development
Quantitative CT metric evaluation
Imaging technology for bronchoscopic and surgical procedures

Target Customers

Pharmaceutical companies Hospitals and healthcare providers Clinical research organizations Medical professionals in pulmonology

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC €7.50M 3
Borski Fund European Innovation Council HERAN Partners
Borski Fund, European Innovation Council +1
01 Aug 2026
Series B €5.00M 2
Borski Fund HERAN Partners
Borski Fund, HERAN Partners
01 Sep 2023
Grant $2.50M 1
European Innovation Council
European Innovation Council
01 Mar 2023
Series A Undisclosed 2
Borski Fund HERAN Partners
Borski Fund, HERAN Partners
01 Oct 2021
Grant Undisclosed -
01 Apr 2019

Thirona Alternatives & Competitors

View All Alternatives
Thirona vs
Perceiv
Perceiv Canada

Pioneering the digital infrastructure for modern neurological care.

Seed
6 employees
AI, Analytics
Thirona vs
Svastia Genetics
Svastia Genetics United Kingdom

Precision genome analytics and novel patient data collections for improving cancer treatment outcome...

Seed
1 employees
Analytics, Biotechnology
Thirona vs
MST - Medical Surgery Technologies
MST - Medical Surgery Technologies Israel

In November 2018, MST Medical Surgery Technologies was acquired by TransEnterix, Inc.

Series C
4 employees
AI, Analytics
View all alternatives

FAQ About Thirona

AI-powered lung image analysis
Thirona was founded in 2014.
Thirona is headquartered in The Netherlands. As of Aug 2026, it also has offices in Nijmegen, The Netherlands.
Thirona operates in Analytics and Health Care. Its work centres on AI-powered Analysis, Thoracic Imaging, Lung Segmentation and Pulmonary Diseases. Its customers include Pharmaceutical companies, Hospitals and healthcare providers and Clinical research organizations.
Thirona has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Project Based.
Thirona has approximately 83 employees.
Thirona has completed 5 funding rounds, raising a total of $15.00M.
Thirona offers: AI-enabled lung image analysis, Advanced segmentation and quantification, Support for clinical trials in drug development, Quantitative CT metric evaluation, Imaging technology for bronchoscopic and surgical procedures.
Top alternatives and competitors to Thirona include Perceiv, Svastia Genetics, MST - Medical Surgery Technologies, SeqOne, Ligence. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thirona and Perceiv are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Thirona, https://bouncewatch.com/company/thirona, updated 28 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes